Baker Bros. Advisors’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-106,999
| Closed | -$510K | – | 120 |
|
|
2022
Q2 | $510K | Hold |
106,999
| – | – | ﹤0.01% | 110 |
|
|
2022
Q1 | $438K | Hold |
106,999
| – | – | ﹤0.01% | 115 |
|
|
2021
Q4 | $730K | Hold |
106,999
| – | – | ﹤0.01% | 120 |
|
|
2021
Q3 | $1.24M | Hold |
106,999
| – | – | 0.01% | 115 |
|
|
2021
Q2 | $1.82M | Hold |
106,999
| – | – | 0.01% | 112 |
|
|
2021
Q1 | $2.12M | Hold |
106,999
| – | – | 0.01% | 114 |
|
|
2020
Q4 | $2.21M | Sell |
106,999
-11,501
| -10% | -$237K | 0.01% | 108 |
|
|
2020
Q3 | $3.12M | Buy |
+118,500
| New | +$3.12M | 0.01% | 92 |
|